Skip to main content
OpenTrials
Completed

NCT Number: NCT06277141

The Vitality Mammography Messaging Study

The investigators will be conducting a randomized controlled trial amongst members of a Wellness Program to test receipt of mammogram using the Whatsapp social media platform and testing various messages.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–75 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Witwatersrand

Johannesburg, Gauteng, South Africa

About this study

The investigators will be conducting a randomised control trial to test the efficacy of WhatsApp messages to increase receipt of mammography amongst eligible women who are members of the Vitality health promotion programme and are also on the Discovery Health Medical Scheme. The study will test a message that 1) has a link to a platform created by the Radiology Society of South Africa which allow members to select a range of practices to book a mammogram, against 2) a message that gives names and telephone numbers of Radiology practices in a 5 km radius of the members home address, against 3) a group with a link to an online platform as well as telephone numbers of radiology practices, against 4) a group where a standard message reminding to go for mammogram will be sent, but without names and telephone numbers of the radiology practices, against 5) a control group where no messages relating to mammography will be sent.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females aged 50 to 75 years, who are members of the Discovery Health Medical Plan and who are also members of Vitality and who have not had a screening mammogram in the preceding three years and who have not previously been diagnosed with breast cancer.

Exclusion criteria

  • CPA Blocks
  • If member's address location, based on their Discovery profile, was further than 5km radius to the Radiologist practice

Treatment and study plan

Standard message

Behavioral

Participants will receive standard messaging based on the Cancer Association of South Africa (CANSA) recommendation on breast cancer screening and a reminder to screen for breast cancer.

Radiology booking site link.

Behavioral

Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site.

Radiology practice telephone numbers

Behavioral

Participants will receive a reminder to screen for breast cancer together with a list and telephone numbers of radiology practices

Radiology site link and telephone numbers

Behavioral

Participants will receive a reminder to screen for breast cancer with a direct online link to a radiology practice booking site and a list and telephone numbers of radiology practices

Primary outcomes

  1. Comparison of mammography screening rates using WhatsApp

    Time frame: Five months

    Comparison of mammography screening rates using an online radiology booking platform, a message with a radiology practice number, to a standard message, all delivered by WhatsApp.

Sponsors and collaborators

Lead sponsor

Wits Health Consortium (Pty) Ltd

Other

Collaborators

  • Discovery Vitality

Registry information

Official study title

The Vitality Mammography Study - Testing the Effectiveness of a Booking Platform on Receipt of Screening Mammography - a Randomized Controlled Trial.

Acronym: VMS

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Feb 26, 2024
Registry last updated
Feb 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.